1. DOP005 Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists. (16th January 2018) Authors: Cohen, R; Bhayat, F; Hantsbarger, G; Blake, A; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S032 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP57 Predictive modelling to examine long term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's Disease. (27th May 2021) Authors: Maruszczak, M; Genenz, K; Turkstra, E; Fenu, E; Hantsbarger, G; Gilaberte, I; Karki, C; Panes, J Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S092 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P131 Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry. (25th January 2019) Authors: Louis, E; Muls, V; Bossuyt, P; Colard, A; Nakad, A; Baert, D; Mana, F; Caenepeel, P; Vanden Branden, S; Vermeire, S; D'Heygere, F; Strubbe, B; Cremer, A; Coche, J-C; Setakhr, V; Baert, F; Vijverman, A; Coenegrachts, J L; Flamme, F; Hantson, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P315 High symptom burden and impact on health-related quality of life in patients with Crohn's perianal fistulas: results from a global burden of illness study. (21st January 2022) Authors: Karki, C; Sharpe, E; Hantsbarger, G; Lee, K; Perovic, M; Raven, L; Sajak-Szczerba, M; Silber, A; Yoon, A; Tozer, P Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P340 Real-world treatment patterns and recurrence rates of rectovaginal fistulas in patients with Crohn's disease: A retrospective cohort database analysis. (27th May 2021) Authors: Karki, C; Latremouille-Viau, D; Gilaberte, I; Hantsbarger, G; Romdhani, H; Lightner, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P516 Discrete choice experiment to examine patient preferences for surgical interventions in patients with Crohn's perianal fistulas: results from a global burden of illness study. (21st January 2022) Authors: Karki, C; Athavale, A; Hantsbarger, G; Lee, K; Milicevic, S; Perovic, M; Raven, L; Sajak-Szczerba, M; Abilash, V; Tozer, P Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P527 Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn's disease from a Belgian registry. (27th May 2021) Authors: Louis, E; Muls, V; Bossuyt, P; Colard, A; Nakad, A; Baert, D; Mana, F; Caenepeel, P; Vanden Branden, S; Vermeire, S; D'Heygere, F; Strubbe, B; Cremer, A; Setakhr, V; Baert, F; Vijverman, A; Coenegrachts, J L; Flamme, F; Hantson, A; Bennett, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P585 Examining faecal incontinence and its impact on health-related quality of life in patients with Crohn's perianal fistulas: results from a multi-country burden of illness study. (21st January 2022) Authors: Karki, C; Athavale, A; Hantsbarger, G; Lee, K; Milicevic, S; Perovic, M; Raven, L; Sajak-Szczerba, M; Sharpe, E; Tozer, P Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P603 INSPIRE: 6-month interim analysis from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn's disease and complex perianal fistulas. (21st January 2022) Authors: Zmora, O; Baumgart, D C; Faubion, W; Ferrante, M; Gecse, K; Genestin, E; Geransar, P; Hantsbarger, G; Karki, C; Tozer, P; Panés, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P724 Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data. (25th January 2019) Authors: Card, T; Ungaro, R; Bhayat, F; Blake, A; Hantsbarger, G; Travis, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗